Dyadic International Inc

DYAI

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001213809

SEC filings (opens in a new tab)

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Dyadic International Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of DYAI: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	32	33	+1
Shares	4.50M	4.50M	+7.33K (+0.2%)
Value	$8.63M	$7.25M	−$1.39M (−16.0%)

New holders (3)

Institutions that held Dyadic International Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to DYAI in Q4 2023
Institution	Shares	Value	% of portfolio
Sabal Trust CO	11,111	$17.9K	0.00%
UBS Group AG	4,517	$7.27K	0.00%
Simplex Trading, LLC	1,271	$2.00K	0.00%

Sold out (2)

Institutions that held Dyadic International Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of DYAI in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Millennium Management LLC	26,545	$51.0K
Atria Wealth Solutions, Inc.	24,136	$46.3K